Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01009905 · ClinicalTrials.gov registry record
An Observational Study (Registry) Assessing Treatment Outcomes and Safety for Children and Adults Who Are Prescribed Norditropin® (Human Growth Hormone)
A clinical trial of Hypopituitarism and Growth Hormone Disorder, sponsored by Novo Nordisk A/S.
- Completed
- Registry status
- 22,960
- Enrollment target
- 1
- Study location
NCT01009905 is a study of Hypopituitarism and Growth Hormone Disorder that has completed, run by Novo Nordisk A/S. The registered enrollment target is 22,960 participants, above the 32-participant average among 3 other Hypopituitarism trials with a reported enrollment target (71650% higher). The trial reports 1 study location across 1 state.
The verdict
NCT01009905, a study of Hypopituitarism and Growth Hormone Disorder, has completed, sponsored by Novo Nordisk A/S.
- COMPLETED
- Registry status
- 22,960 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is conducted in the United States of America (USA). The aim of this observational study is to collect data concerning the treatment outcomes and safety for children and adults who are prescribed Norditropin®. Specific objectives include: 1) developing models defining the relationship of Norditropin dose to changes in insulin-like growth factor (IGF-I) and treatment outcomes, accounting for independent factors such as age, gender and puberty and 2) determining the relative predictive values of peak growth hormone (GH) and IGF-I levels and other factors before treatment to clinical outcomes.
Conditions Studied
Interventions
- DRUG somatropin
Study Locations (1)
New Jersey
- Novo Nordisk Investigational Site - Plainsboro
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22,960 participants |
| Start Date | 2002-06-24 |
| Est. Completion | 2016-09-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01009905
The ClinicalTrials.gov registry entry for NCT01009905 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 22,960 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 32-participant average among 3 other Hypopituitarism trials with a reported enrollment target (71650% higher). The listed sponsor is Novo Nordisk A/S, which has 431 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Hypopituitarism appearing as the primary indexed condition, and to 1 intervention - of which somatropin is the first listed.
NCT01009905 reports 1 study location spanning 1 distinct geographic area - top geographies include New Jersey.
Frequently Asked Questions
What is clinical trial NCT01009905 about?
NCT01009905 is a clinical study titled "An Observational Study (Registry) Assessing Treatment Outcomes and Safety for Children and Adults Who Are Prescribed Norditropin® (Human Growth Hormone)". This study is conducted in the United States of America (USA). The aim of this observational study is to collect data concerning the treatment outcomes and safety for children and adults who are prescribed Norditropin®. Specific objectives include: 1) developing models defining the relationship of N...
What is the current status of trial NCT01009905?
This trial is currently completed. The enrollment target is 22,960 participants. The study started on 2002-06-24. Estimated completion is 2016-09-30.
What conditions does trial NCT01009905 study?
This clinical trial studies the following conditions: Hypopituitarism, Growth Hormone Disorder, Pituitary Dwarfism.
What interventions are being tested in trial NCT01009905?
The interventions under investigation include: somatropin (DRUG).
Who is sponsoring clinical trial NCT01009905?
This trial is sponsored by Novo Nordisk A/S, which has 431 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01009905 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypopituitarism
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.